Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Venous Thrombosis 1 Venous Thromboembolism 1 Upper Extremity Deep Vein Thrombosis 1 Recurrence 1 Lung Neoplasms 1 Hemorrhage 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Propofol 3 Oxaliplatin 3 Morphine 3 Fentanyl 3 Sevoflurane 2 Ropivacaine 2 Fluorouracil 2 Capecitabine 2 Bupivacaine 2 Bevacizumab 2 Acetaminophen 2 polyethylene glycol 3350 1 oxycodone-acetaminophen 1 gatorade 1 fish oil triglycerides 1 Vitamin D 1 Tranexamic Acid 1 Tramadol 1 Tegafur 1 Sodium Chloride 1 Simethicone 1 Saline Solution 1 Rivaroxaban 1 Polyethylene Glycols 1 Pirinitramide 1 Panitumumab 1 Orphenadrine 1 Neuroleptanalgesia 1 Midazolam 1 Methadone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Colonic Neoplasms × Rivaroxaban × Clear all

NCT05303818 2022-03-31

Ésquilo

Hospital do Servidor Publico Estadual

Phase 4 Unknown

Gastrointestinal

Colonic Neoplasms, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡